Download PDF
Am J Perinatol 2022; 39(15): 1654-1658
DOI: 10.1055/s-0041-1724000
Original Article

Gestational and Age-Specific Cystatin C Reference Intervals for Newborns

Chao Tong
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Yalan Liu
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Yanqiu Wu
2   Department of Neonatal, Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China
,
Qiong Li
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Yipin Wu
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Lin Wang
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Yan Chen
1   Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
› Author Affiliations Funding This work was supported by National Nature Science Foundation of China (grant numbers: 81300523 and 81601324).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Cystatin C (CysC) references are useful for the monitoring of renal function in neonates. However, the standard CysC references in newborn infants have not been determined. The aim of this study was to establish a useful reference range for CysC in newborns.

Study Design Serum CysC levels were measured in 1,919 blood samples from 1,044 newborns during their first 28 days of life. CysC levels were analyzed for associations between subgroups dichotomized by postnatal age (PA) and gestational age (GA). The serum CysC reference intervals were determined according to the PA and GA. The associations between the serum CysC level and other biochemical parameters as well as perinatal factors were also analyzed.

Results In this study, the mean GA was 35.8 ± 2.9 weeks and the birth weight (BW) was 2,614 ± 697 g. Reference ranges of serum CysC were determined, and a general decreasing trend of CysC levels was observed as the GA increased. CysC levels differed significantly among the PA and GA categories (p < 0.001). Serum CysC levels were relatively stable throughout the GA range but were impacted by the white blood cell count within the first postnatal 24 hours. Moreover, CysC levels always correlated positively with serum creatinine concentrations (p < 0.001). Serum Cr levels were influenced by multiple factors, including BW, GA, total bilirubin, direct bilirubin, white blood cell count, C-reactive protein, and blood urea nitrogen.

Conclusion Reference levels of serum CysC should be determined according to the PA and GA. In contrast to Cr, serum CysC is a reliable index for assessing renal function in neonates as it is influenced by very few factors. The CysC reference levels will allow neonatologists to accurately evaluate renal function in the neonatal population.

Key Points

  • Cystatin C is a useful marker of the glomerular filtration rate in neonates.

  • A reference range for cystatin C using 1,919 blood samples of 1,044 newborns was determined.

  • In contrast to creatinine, only a few nonrenal factors influence serum cystatin C.

Keywords

cystatin C - newborn - reference - renal function - creatinine

Supplementary Material



Publication History

Received: 10 May 2020

Accepted: 14 January 2021

Article published online:
23 February 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 van den Anker JN, Allegaert K. Pharmacokinetics of aminoglycosides in the newborn. Curr Pharm Des 2012; 18 (21) 3114-3118
    CrossrefPubMedSearch in Google Scholar
  • 2 Bartelink IH, Rademaker CMA, Schobben AFAM, van den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45 (11) 1077-1097
    CrossrefPubMedSearch in Google Scholar
  • 3 Demirel G, Celik IH, Canpolat FE, Erdeve O, Biyikli Z, Dilmen U. Reference values of serum cystatin C in very low-birthweight premature infants. Acta Paediatr 2013; 102 (01) e4-e7
    CrossrefPubMedSearch in Google Scholar
  • 4 Askenazi DJ, Koralkar R, Levitan EB. et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res 2011; 70 (03) 302-306
    CrossrefPubMedSearch in Google Scholar
  • 5 Softić A, Begić L, Halilbašić A, Vižin T, Kos J. The predictive value of cystatin C in monitoring of B non-hodgkin lymphomas: relation to biochemical and clinical parameters. ISRN Oncol 2013; 2013: 752792
    PubMedSearch in Google Scholar
  • 6 Allegaert K, Mekahli D, van den Anker J. Cystatin C in newborns: a promising renal biomarker in search for standardization and validation. J Matern Fetal Neonatal Med 2015; 28 (15) 1833-1838
    CrossrefPubMedSearch in Google Scholar
  • 7 Plebani M, Mussap M, Bertelli L. et al. Determination of blood cystatin C in pregnant women during labor and in their newborns. Determinazione della cistatina C sierica in gestanti al momento del parto e nei loro neonati. Med Surg Pediatr 1997; 19 (05) 325-329
    PubMedSearch in Google Scholar
  • 8 Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999; 16 (06) 287-295
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40 (02) 221-226
    CrossrefPubMedSearch in Google Scholar
  • 10 Abitbol CL, Seeherunvong W, Galarza MG. et al. Neonatal kidney size and function in preterm infants: what is a true estimate of glomerular filtration rate?. J Pediatr 2014; 164 (05) 1026-1031.e2
    CrossrefPubMedSearch in Google Scholar
  • 11 Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G. Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol 2003; 169 (06) 2312-2315
    CrossrefPubMedSearch in Google Scholar
  • 12 Treiber M, Pecovnik-Balon B, Gorenjak M. Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn. Wien Klin Wochenschr 2006; 118 (9–10, Suppl 2): 66-70
    CrossrefPubMedSearch in Google Scholar
  • 13 Lee J-H, Hahn W-H, Ahn J, Chang J-Y, Bae C-W. Serum cystatin C during 30 postnatal days is dependent on the postconceptional age in neonates. Pediatr Nephrol 2013; 28 (07) 1073-1078
    CrossrefPubMedSearch in Google Scholar
  • 14 Timovska SN, Cekovska S, Tosheska-Trajkovska K. Acute kidney injury in newborns. Prilozi (Makedon Akad Nauk Umet Odd Med Nauki) 2015; 36 (03) 83-89
    PubMedSearch in Google Scholar
  • 15 Roos JF, Doust J, Tett SE, Kirkpatrick CMJ. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. Clin Biochem 2007; 40 (5-6): 383-391
    CrossrefPubMedSearch in Google Scholar
  • 16 Novo AC, Sadeck LdosS, Okay TS, Leone CR. Longitudinal study of Cystatin C in healthy term newborns. Clinics (São Paulo) 2011; 66 (02) 217-220
    CrossrefPubMedSearch in Google Scholar
  • 17 Kandasamy Y, Smith R, Wright IMR. Measuring cystatin C to determine renal function in neonates. Pediatr Crit Care Med 2013; 14 (03) 318-322
    CrossrefPubMedSearch in Google Scholar
  • 18 Yang Y, Li S-J, Pan J-J. et al. Reference values for serum cystatin C in very low-birthweight infants: From two centres of China. J Paediatr Child Health 2017
    PubMedSearch in Google Scholar
  • 19 Bardallo Cruzado L, Pérez González E, Martínez Martos Z. et al. Serum cystatin C levels in preterm newborns in our setting: correlation with serum creatinine and preterm pathologies. Nefrologia 2015; 35 (03) 296-303
    PubMedSearch in Google Scholar
  • 20 Andersen TB, Eskild-Jensen A, Frøkiaer J, Brøchner-Mortensen J. Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review. Pediatr Nephrol 2009; 24 (05) 929-941
    CrossrefPubMedSearch in Google Scholar
  • 21 Treiber M, Pečovnik Balon B, Gorenjak M. A new serum cystatin C formula for estimating glomerular filtration rate in newborns. Pediatr Nephrol 2015; 30 (08) 1297-1305
    CrossrefPubMedSearch in Google Scholar
  • 22 Muhari-Stark E, Burckart GJ. Glomerular filtration rate estimation formulas for pediatric and neonatal use. J Pediatr Pharmacol Ther 2018; 23 (06) 424-431
    PubMedSearch in Google Scholar
  • 23 Drukker A, Guignard JP. Renal aspects of the term and preterm infant: a selective update. Curr Opin Pediatr 2002; 14 (02) 175-182
    CrossrefPubMedSearch in Google Scholar
  • 24 Nakashima T, Inoue H, Fujiyoshi J, Matsumoto N. Longitudinal analysis of serum cystatin C for estimating the glomerular filtration rate in preterm infants. Pediatr Nephrol 2016; 31 (06) 983-989
    CrossrefPubMedSearch in Google Scholar
  • 25 Abdelaal NA, Shalaby SA, Khashana AK, Abdelwahab AM. Serum cystatin C as an earlier predictor of acute kidney injury than serum creatinine in preterm neonates with respiratory distress syndrome. Saudi J Kidney Dis Transpl 2017; 28 (05) 1003-1014
    CrossrefPubMedSearch in Google Scholar
  • 26 Askenazi DJ, Griffin R, McGwin G, Carlo W, Ambalavanan N. Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case-control analysis. Pediatr Nephrol 2009; 24 (05) 991-997
    CrossrefPubMedSearch in Google Scholar
  • 27 Armangil D, Yurdakök M, Canpolat FE, Korkmaz A, Yiğit S, Tekinalp G. Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants. Pediatr Nephrol 2008; 23 (11) 2081-2083
    CrossrefPubMedSearch in Google Scholar
  • 28 Kar S, Paglialunga S, Islam R, Cystatin C. Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies. J Clin Pharmacol 2018; 58 (10) 1239-1247
    CrossrefPubMedSearch in Google Scholar
  • 29 Herget-Rosenthal S, Bökenkamp A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations?. Clin Biochem 2007; 40 (3-4): 153-161
    CrossrefPubMedSearch in Google Scholar
  • 30 Taglieri N, Koenig W, Kaski C. [Cystatin C and cardiovascular risk]. Klin Lab Diagn 2012; 10 (10) 65-72
    PubMedSearch in Google Scholar
  • 31 Knight EL, Verhave JC, Spiegelman D. et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65 (04) 1416-1421
    CrossrefPubMedSearch in Google Scholar
  • 32 Stevens LA, Schmid CH, Greene T. et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75 (06) 652-660
    Search in Google Scholar
  • 33 Evangelopoulos AA, Vallianou NG, Bountziouka V. et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J 2012; 42 (05) 517-522
    CrossrefPubMedSearch in Google Scholar